INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE

Their core work

Portugal's national public health institute, INSA conducts epidemiological surveillance, human biomonitoring, and laboratory reference services across infectious diseases, food safety, and environmental health. They operate as a key node in European disease surveillance networks, contributing population-level health data, biomonitoring expertise, and analytical laboratory capacity. Their work spans from tracking vaccine effectiveness and congenital anomalies to monitoring chemical exposures in human populations and ensuring food safety through metrology standards. They also play a growing role in genomic data infrastructure and pandemic preparedness.

What they specialise in

How they've shifted over time

Early H2020 participation (2015–2018) centered on building research infrastructure foundations — establishing legal frameworks, funding mechanisms, and operational procedures for pan-European networks (ERINHA2, PRO-METROFOOD), alongside traditional surveillance work on vaccine effectiveness and congenital anomalies. From 2019 onward, the focus shifted decisively toward FAIR data principles, genomic infrastructure, rare disease data sharing, and pandemic response — reflecting a broader move from physical laboratory networks to digital health data ecosystems. The COVID-19 pandemic accelerated their pivot toward real-time surveillance systems and pandemic preparedness tools.

INSA is moving from traditional lab-based public health work toward data-driven health intelligence, with growing emphasis on FAIR genomic data, digital surveillance platforms, and cross-border health data interoperability.

How they like to work

INSA operates exclusively as a consortium participant — across all 13 H2020 projects, they never led as coordinator. They consistently join large-scale European consortia (384 unique partners across 41 countries), acting as a reliable national data contributor and laboratory node rather than a project driver. This makes them an easy, low-risk partner to include in proposals: they bring national-level health data, established laboratory capacity, and strong institutional continuity without competing for leadership roles.

Exceptionally broad network of 384 unique partners spanning 41 countries, built through participation in large pan-European health consortia. Their connections are strongest across EU public health institutes, university hospitals, and food safety authorities.

What sets them apart

INSA occupies a distinctive niche as a national public health institute that bridges health surveillance, food safety, and environmental monitoring under one roof — a combination few single organizations offer. Their dual strength in both wet-lab biomonitoring (chemical exposure, pathogen analysis) and increasingly in health data infrastructure (FAIR principles, genomic databases) makes them particularly valuable for projects needing both biological sample analysis and population-level data. For consortium builders, they represent guaranteed access to Portuguese national health data and regulatory networks, which is essential for any project claiming pan-European coverage.

Highlights from their portfolio

• One Health EJP
  Their largest H2020 grant (EUR 1.3M) addressing the critical intersection of food safety, zoonotic diseases, and antimicrobial resistance under the One Health framework.
• HBM4EU
  Second-largest grant (EUR 1M+) in the flagship European human biomonitoring initiative — signals INSA as a trusted national biomonitoring hub.
• B1MG
  Positions INSA in the strategic Beyond 1 Million Genomes initiative building Europe's genomic data infrastructure, signaling their move into personalized medicine data systems.